X-82: Phase I data

Data from 21 patients with solid tumors in the Phase I portion of an open-label, U.S. Phase I/II trial showed that

Read the full 210 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE